|
57
|
223
|
1v2vT |
Benzamidine in complex with bovine trypsin variant x(ssai)bt.c1 |
|
55
|
223
|
1v2sT |
Benzamidine in complex with bovine trypsin variant x(ssfi.glu)bt.d1 |
|
43
|
259
|
1vitH |
Thrombin:hirudin 51-65 complex |
|
56
|
312
|
1vcwA |
Crystal structure of degs after backsoaking the activating peptide |
|
58
|
233
|
1v3xA |
Factor xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine |
|
50
|
223
|
1v2tT |
Trypsin inhibitor in complex with bovine trypsin variant x(ssfi.glu)bt.b4 |
|
53
|
223
|
1utnA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
76
|
302
|
1uk2A |
Crystal structure of sars coronavirus main proteinase (3clpro) at ph8.0 |
|
64
|
240
|
1uvpA |
Structure of the complex of porcine pancreatic elastase in complex with cadmium refined at 1.85 a resolution (crystal b) |
|
44
|
254
|
1uvuH |
Bovine thrombin--bm12.1700 complex |
|
48
|
222
|
1utjA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
65
|
240
|
1uo6A |
Porcine pancreatic elastase/xe-complex |
|
57
|
223
|
1utqA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
51
|
222
|
1utlM |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
79
|
301
|
1uk3A |
Crystal structure of sars coronavirus main proteinase (3clpro) at ph7.6 |
|
47
|
254
|
1uvsH |
Bovine thrombin--bm51.1011 complex |
|
59
|
223
|
1utoA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
56
|
259
|
1umaH |
Alpha-thrombin (hirugen) complexed with na-(n,n-dimethylcarbamoyl)-alpha-azalysine |
|
20
|
122
|
1uw7A |
Nsp9 protein from sars-coronavirus. |
|
58
|
223
|
1utpA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
51
|
222
|
1utkA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
84
|
301
|
1uk4A |
Crystal structure of sars coronavirus main proteinase (3clpro) complexed with an inhibitor |
|
64
|
240
|
1uvoA |
Structure of the complex of porcine pancreatic elastase in complex with cadmium refined at 1.85 a resolution (crystal a) |
|
52
|
255
|
1uvtH |
Bovine thrombin--bm14.1248 complex |
|
52
|
222
|
1utmA |
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements |
|
16
|
125
|
1uhbA |
Crystal structure of porcine alpha trypsin bound with auto catalyticaly produced native peptide at 2.15 a resolution |
|
18
|
150
|
1ucyH |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
19
|
98
|
1uhbB |
Crystal structure of porcine alpha trypsin bound with auto catalyticaly produced native peptide at 2.15 a resolution |
|
21
|
109
|
1ucyE |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
56
|
259
|
1ucyK |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
85
|
301
|
1uj1A |
Crystal structure of sars coronavirus main proteinase (3clpro) |
|
49
|
245
|
1u6qA |
Substituted 2-naphthamadine inhibitors of urokinase |
|
58
|
257
|
1tmtH |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms |
|
58
|
223
|
1tynA |
Atomic structure of the trypsin-cyclotheonamide a complex: lessons for the design of serine protease inhibitors |
|
54
|
224
|
1tryA |
Structure of inhibited trypsin from fusarium oxysporum at 1.55 angstroms |
|
52
|
223
|
1tnkA |
Prediction of novel serine protease inhibitors |
|
56
|
259
|
1tmbH |
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide a |
|
52
|
257
|
1thpB |
Structure of human alpha-thrombin y225p mutant bound to d-phe-pro-arg-chloromethylketone |
|
48
|
223
|
1tgtA |
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography |
|
55
|
223
|
1tx8A |
Bovine trypsin complexed with amso |
|
54
|
223
|
1tpsA |
Atomic structure of the trypsin-a90720a complex: a unified approach to structure and function |
|
57
|
259
|
1thrH |
Structures of thrombin complexes with a designed and a natural exosite inhibitor |
|
55
|
259
|
1twxB |
Crystal structure of the thrombin mutant d221a/d222k |
|
55
|
224
|
1trnA |
Crystal structure of human trypsin 1: unexpected phosphorylation of tyrosine 151 |
|
55
|
223
|
1tldA |
Crystal structure of bovine beta-trypsin at 1.5 angstroms resolution in a crystal form with low molecular packing density. active site geometry, ion pairs and solvent structure |
|
51
|
223
|
1tfxA |
Complex of the second kunitz domain of tissue factor pathway inhibitor with porcine trypsin |
|
46
|
223
|
1tgbA |
Crystal structure of bovine trypsinogen at 1.8 angstroms resolution. ii. crystallographic refinement, refined crystal structure and comparison with bovine trypsin |
|
53
|
223
|
1tppA |
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors |
|
50
|
223
|
1tpaE |
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors |
|
46
|
223
|
1tgcA |
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography |
